“Few aspects of healthcare have been disrupted during the past several months as much as the physician experience,” says Christine Franklin, executive director of the DHC Group. “In addition to the interruption of sales rep access, physician offices closed their office doors at the peak of the pandemic-shutdown. This left pharmaceutical marketers and their partners looking for options to ensure physicians were getting adequate information and that the patient education stream was not disrupted. At the same time, we were hearing from patient advocates about the increasing need for reliable health content to be delivered to concerned chronic condition suffers.”
In response, digital innovators stepped up and announced virtual waiting room options to ensure patients could get the information they needed, even if they weren’t able to see their doctors in person. To better understand the impact of the new virtual health landscape, the DHC Group recently conducted research including thought leader roundtables, physician surveys via the SERMO network, and interviews with pharma marketers, including Intouch director of innovation, Brendon Thomas. The experts weighed in on opportunities for communicating with physicians and patients virtually, how virtual care can complement in-person care, and where payers fit in the virtual-care setting; to learn more, read the entire article here.